A novel missense mutation in the caveolin‐3 gene in rippling muscle disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Muscle and Nerve

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mus.20781PMID 17405141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new missense mutation in caveolin-3 gene causes rippling muscle disease.

  2006cited by this paper
• Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation

  2005cited by this paper
• Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.

  2004cited by this paper
• Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease

  2004cited by this paper
• A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia.

  2004cited by this paper
• Homozygous mutations in caveolin‐3 cause a severe form of rippling muscle disease

  2003cited by this paper
• Rippling muscle disease: A review

  2002cited by this paper
• Mutations in the caveolin-3 gene: When are they pathogenic?

  2001cited by this paper
• Severe autosomal recessive rippling muscle disease

  2001cited by this paper
• A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation

  2001cited by this paper
• The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.

  2001cited by this paper
• Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease

  2001cited by this paper
• Caveolin-3 in muscular dystrophy.

  1998cited by this paper
• Rippling muscle disease.

  1989cited by this paper
• [Increased muscular irritability syndrome: treatment with nifedipine. Report of a case].

  1984cited by this paper
• [Increased muscular irritability syndrome: treatment with nifedipine. Report of a case].

  1984cited by this paper
• A FAMILY WITH DOMINANT HEREDITARY MYOTONIA, MUSCULAR HYPERTROPHY, AND INCREASED MUSCULAR IRRITABILITY, DISTINCT FROM MYOTONIA CONGENITA THOMSEN

  1975cited by this paper

• Clinical Phenotype Spectrum in Two Large Chinese Families With Rippling Muscle Disease Caused by CAV‐3 c.80G>A

  2025cites this paper
• Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease

  2025cites this paper
• The spectrum of rippling muscle disease

  2024cites this paper
• Stiffness syndromes

  2021cites this paper
• Immune-mediated rippling muscle disease in a patient with treated hypothyroidism.

  2017cites this paper
• Chapter 11 – Stiffness syndromes

  2011cites this paper
• Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.

  2011cites this paper
• Rippling is not always electrically silent in rippling muscle disease

  2011cites this paper
• Domain specific over-expression of a peptide encoded by an I-band domain of the human TTN gene; the role of titin exons 248 – 250 in C2C12 myogenesis

  2011influential citation
• Caveolinopathies: from the biology of caveolin-3 to human diseases

  2010cites this paper
• Caveolins in the development and diseases of musculoskeletal system.

  2009cites this paper
• List of papers

  1995cites this paper